2003
Glutathione S-transferase M1 and T1 genetic polymorphisms, alcohol consumption and breast cancer risk
Zheng T, Holford T, Zahm S, Owens P, Boyle P, Zhang Y, Zhang B, Wise J, Stephenson L, Ali-Osman F. Glutathione S-transferase M1 and T1 genetic polymorphisms, alcohol consumption and breast cancer risk. British Journal Of Cancer 2003, 88: 58-62. PMID: 12556960, PMCID: PMC2376773, DOI: 10.1038/sj.bjc.6600708.Peer-Reviewed Original ResearchConceptsBreast cancer riskGSTT1 null genotypeCancer riskAlcohol consumptionGST genotypesBreast cancerPostmenopausal womenGenetic polymorphismsIncident breast cancer patientsGlutathione S-transferase M1Breast cancer patientsT1 genetic polymorphismsCase-control studyGSTT1 genetic polymorphismsGlutathione S-transferaseS-transferase M1Cancer patientsEffect modificationGSTM1 genotypeHigh riskNew Haven CountyYounger ageCancerWomenRisk
2002
Radiation exposure from diagnostic and therapeutic treatments and risk of breast cancer
Zheng T, Holford TR, Mayne ST, Luo J, Owens PH, Zhang B, Zhang W, Zhang Y. Radiation exposure from diagnostic and therapeutic treatments and risk of breast cancer. European Journal Of Cancer Prevention 2002, 11: 229-235. PMID: 12131656, DOI: 10.1097/00008469-200206000-00006.Peer-Reviewed Original ResearchConceptsBreast cancerTherapeutic radiation treatmentRadiation treatmentOdds ratioTherapeutic radiationSkin problemsBreast cancer risk factorsRadiation exposureCancer risk factorsBreast cancer riskCase-control studyDiagnostic X-ray exposurePostmenopausal womenRisk factorsCancer riskHigh riskYounger ageTherapeutic treatmentCancerDiagnostic X-raysPerson interviewsTreatmentX-ray exposureRiskStructured questionnaire
2001
Lactation and breast cancer risk: a case–control study in Connecticut
Zheng T, Holford T, Mayne S, Owens P, Zhang Y, Zhang B, Boyle P, Zahm S. Lactation and breast cancer risk: a case–control study in Connecticut. British Journal Of Cancer 2001, 84: 1472-1476. PMID: 11384096, PMCID: PMC2363665, DOI: 10.1054/bjoc.2001.1793.Peer-Reviewed Original ResearchConceptsBreast cancer riskBreast cancerCancer riskIncident breast cancer casesMajor risk factorCase-control studyBreast cancer casesRisk reductionMenopausal statusParous womenPostmenopausal womenInverse associationRisk factorsCancer casesStudy interviewersFurther stratificationFirst childWomenStructured questionnaireLifetime durationCancerRiskLactationChildrenBreastfeeding
1999
β‐Benzene hexachloride in breast adipose tissue and risk of breast carcinoma
Zheng T, Holford T, Mayne S, Owens P, Ward B, Carter D, Dubrow R, Zahm S, Boyle P, Tessari J. β‐Benzene hexachloride in breast adipose tissue and risk of breast carcinoma. Cancer 1999, 85: 2212-2218. PMID: 10326700, DOI: 10.1002/(sici)1097-0142(19990515)85:10<2212::aid-cncr16>3.0.co;2-f.Peer-Reviewed Original ResearchConceptsBreast adipose tissueAdipose tissue levelsBreast carcinoma riskBreast carcinoma casesBreast carcinomaAdipose tissueCarcinoma casesCarcinoma riskTissue levelsBenign breast diseaseProgesterone receptor statusPatients age 40Association of exposurePrimary breast carcinomaLogistic regression modelsPostmenopausal womenMenopausal statusParous womenNulliparous womenReceptor statusHighest quartilePotential confoundersBreast diseaseΒ-benzene hexachlorideConnecticut women
1985
Risk Factors for Fibrocystic Breast Disease and Its Histopathologic Components2
Berkowitz G, Kelsey J, LiVolsi V, Holford T, Merino M, Ort S, O'Connor T, White C. Risk Factors for Fibrocystic Breast Disease and Its Histopathologic Components2. Journal Of The National Cancer Institute 1985, 75: 43-50. PMID: 3859695, DOI: 10.1093/jnci/75.1.43.Peer-Reviewed Original ResearchConceptsFibrocystic breast diseaseBenign breast diseaseBreast diseaseHigher socioeconomic statusOdds ratioLow Quetelet's indexSocioeconomic statusBreast cancer patientsCase-control studyEpidemiologic similaritiesCurrent smokersPostmenopausal womenPremenopausal womenEpithelial atypiaGross cystsFibrocystic diseaseCancer patientsPapillary hyperplasiaQuetelet indexBiopsy specimensRisk factorsSurgical conditionsConnecticut hospitalsLow parityBreast cancerESTROGEN REPLACEMENT THERAPY AND FIBROCYSTIC BREAST DISEASE IN POSTMENOPAUSAL WOMEN1
BERKOWITZ G, KELSEY J, HOLFORD T, LIVOLSI V, MERINO M, BECK G, ORT S, O'CONNOR T, WHITE C. ESTROGEN REPLACEMENT THERAPY AND FIBROCYSTIC BREAST DISEASE IN POSTMENOPAUSAL WOMEN1. American Journal Of Epidemiology 1985, 121: 238-245. PMID: 4014118, DOI: 10.1093/oxfordjournals.aje.a113994.Peer-Reviewed Original ResearchConceptsFibrocystic breast diseaseEstrogen replacement therapyBreast diseaseReplacement therapyPostmenopausal womenHospital-based case-control studyMedical care utilizationPossible risk factorsCase-control studyDuration of useOdds of diseasePostmenopausal women1Care utilizationMenopausal estrogensExcess oddsRisk factorsSurgical conditionsTherapyDiseasePositive associationMore yearsWomenOddsAssociationEstrogen
1984
Exogenous hormone use and fibrocystic breast disease by histopathologic component
Berkowitz G, Kelsey J, Livolsi V, Merino M, Holford T, Hildreth N, Ort S, O'Connor T, White C. Exogenous hormone use and fibrocystic breast disease by histopathologic component. International Journal Of Cancer 1984, 34: 443-449. PMID: 6490201, DOI: 10.1002/ijc.2910340403.Peer-Reviewed Original ResearchConceptsFibrocystic breast diseaseEstrogen replacement therapyBreast diseaseGross cystsReplacement therapyHospital-based case-control studyExogenous hormone useOral contraceptive usePost-menopausal womenCase-control studyPostmenopausal womenPremenopausal womenHormone useOral contraceptivesEpithelial atypiaControl womenPapillary hyperplasiaBiopsy specimensFibrocystic lesionsSurgical conditionsContraceptive useHistopathologic componentsWomenIncreased occurrenceDiseaseORAL CONTRACEPTIVE USE AND FIBROCYSTIC BREAST DISEASE AMONG PRE- AND POSTMENOPAUSAL WOMEN1
BERKOWITZ G, KELSEY J, LIVOLSI V, HOLFORD T, MERINO M, ORT S, O'CONNOR T, GOLDENBERG I, WHITE C. ORAL CONTRACEPTIVE USE AND FIBROCYSTIC BREAST DISEASE AMONG PRE- AND POSTMENOPAUSAL WOMEN1. American Journal Of Epidemiology 1984, 120: 87-96. PMID: 6741927, DOI: 10.1093/oxfordjournals.aje.a113878.Peer-Reviewed Original ResearchConceptsFibrocystic breast diseaseOral contraceptive useBreast diseaseOral contraceptivesContraceptive useHospital-based case-control studyOral contraceptive exposureGeneral surgical serviceCase-control studyLong-term useContraceptive exposurePostmenopausal women1Postmenopausal womenPremenopausal womenCystic diseaseStudy groupSurgical servicesDecreased frequencyPast usersDiseaseIncreased occurrenceWomenContraceptivesNegative associationAssociation
1982
Effect of age at first childbirth on risk of developing specific histologic subtype of breast cancer
Livolsi V, Kelsey J, Fischer D, Holford T, Mostow E, Goldenberg I. Effect of age at first childbirth on risk of developing specific histologic subtype of breast cancer. Cancer 1982, 49: 1937-1940. PMID: 6280850, DOI: 10.1002/1097-0142(19820501)49:9<1937::aid-cncr2820490931>3.0.co;2-h.Peer-Reviewed Original ResearchConceptsBreast cancerRisk factorsHistologic subtypeLobular carcinomaSpecific histologic subtypesBenign breast diseaseBreast cancer riskCase-control studyFirst childLater ageVariety of cancersPostmenopausal womenDuct cancerEffect of ageNulliparous womenDuctal carcinomaHistopathologic subtypeEpidemiologic variablesLobular tumorsBreast diseaseBreast carcinomaFamily historyCancer riskBody weightComparison women